Fundamental dimension Equity attribute | CDAQPeer $10.74▼-0.28% Cap $83.68MP/E -2.8x QuantScore33/100 | AAGRPeer $0.0070.00% Cap $405.1KP/E -0.0x QuantScore41/100 | BACALeader $10.65▲+0.09% Cap $84.59MP/E -7.8x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
31/100 |
72/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 33/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 20/100 | 25/100 |
Growth Revenue / earnings growth & margins | 21/100 | 37/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.8x | -0.0x | -7.8x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -24.2x | -0.2x | -34.0x |
Price / Sales | — | 0.2x | — |
Price / Free Cash Flow | -123.0x | -0.1x | -3.5x |
PEG ratio | 0.00 | 0.00 | 0.02 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 2 / 9 | 1 / 9 |
Altman Z-Score | -23.91 (Distress) | -16.27 (Distress) | -5.84 (Distress) |
Total debt / equity | 0.00 | -0.52 | -0.01 |
Quick ratio | 0.0x | 0.1x | 0.0x |
Interest coverage | — | -24.6x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | +167.6% | — |
Net income growth YoY | +15.6% | -64.0% | -290.5% |
Gross margin (TTM) | 0.0% | 25.2% | 0.0% |
Operating margin (FY) | — | -2253.9% | — |
FCF margin (FY) | — | -219.2% | — |
5. Trailing price performancePrice change over period |
1M return | -0.1% | +699900.0% | +0.1% |
3M return | -0.1% | 0.0% | -0.1% |
6M return | -0.7% | -29.3% | +2.5% |
Year to date | +1.6% | +699900.0% | +3.9% |
1Y return | +1.9% | +40.0% | +3.9% |
3Y return | +11.3% | -99.9% | +9.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | $-0.5869 -8484.1% premium | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |